Effect of intrapulmonary tetrahydrocannabinol administration in humans.
Zuurman L, Roy C, Schoemaker RC, Hazekamp A, den Hartigh J, Bender JC, Verpoorte R, Pinquier JL, Cohen AF, van Gerven JM.
Zuurman L, et al. Among authors: hazekamp a.
J Psychopharmacol. 2008 Sep;22(7):707-16. doi: 10.1177/0269881108089581. Epub 2008 May 30.
J Psychopharmacol. 2008.
PMID: 18515447
Clinical Trial.